20
Curia Spain Sau, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
One of their notable products is PREDNISONE ANHYDROUS USP, with a corresponding US DMF Number 13173.
Remarkably, this DMF maintains an Active status since its submission on August 06, 1998, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 24, 2012, and payment made on December 05, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II